ONC FY 2023 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

FY 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$2.5B+73.7% YoY

Gross Profit

$2.1B84.5% margin

Operating Income

-$1.2B-49.1% margin

Net Income

-$882M-35.9% margin

EPS (Diluted)

$-8.45

Cash Flow

Operating Cash Flow

-$1.2B

Free Cash Flow

-$1.8B

Stock-Based Comp.

$368M

Balance Sheet

Total Assets

$5.8B

Total Liabilities

$2.3B

Stockholders' Equity

$3.5B

Cash & Equivalents

$3.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.5B	$1.4B	+73.7%
Gross Profit	$2.1B	$1.1B	+84.1%
Operating Income	-$1.2B	-$1.8B	+32.5%
Net Income	-$882M	-$2.0B	+56.0%